ReviewPreventive medicine reports2025
Effectiveness of mobile health technology-enabled interventions to improve management and control of hypertension and diabetes in India- a systematic review.
Review in Preventive medicine reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Effect of digital health interventions on glycaemic control among type 2 diabetes individuals in low and middle-income countries: a systematic review and meta-analysis.BMC public health · 2026Pooled it
- Review
- Asia at the Epicenter of the Global Cardiometabolic Shift.JACC. Asia · 2026Review
- Barriers and facilitators to the use of Hypercare APK app in hypertension management: a qualitative inquiry into highly educated participants' experiences in Ilorin, Nigeria.Frontiers in digital health · 2026Article
- Artificial Intelligence-Enabled Mobile Health Intervention (mDiabetes) to Reduce Diabetes Risk Behaviors in Rural India: Quasi-Experimental Pre-Post Study.Journal of medical Internet research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: In India, due to rapid urbanization, lifestyle changes, and the aging of the population, hypertension and diabetes have become the leading causes of morbidity and mortality over the past 20 years. The aim of this study is to evaluate the impact of mobile health (mHealth) technology interventions on hypertension and diabetes control in India. Methods: A comprehensive search in PubMed, Cochrane Library, Dimensions, and Google Scholar was conducted for studies conducted in India and published from inception to October 15th, 2024. The retrieved studies assessed the impact of mHealth technology interventions on hypertension and diabetes control in India. The Population, Intervention, Comparator, Outcomes, & Study Design (PICOS) framework outlined the key elements of the review. This systematic review uses secondary data, so no ethical approval is needed. Results: Of 782 potential articles assessed, eight met the inclusion criteria. mHealth technology-enabled Interventions were associated with significantly improved blood pressure, glycated hemoglobin (HbA1c) and Fasting Blood Glucose (FBG) in the intervention group compared to the control group. Additionally, digital health interventions, such as SMS-based education and mHealth platforms, greatly improve treatment adherence and patient satisfaction. Conclusion: Due to an increasing burden of chronic diseases, incorporating mHealth interventions in routine healthcare could be a game-changing strategy toward improved health outcomes, especially in areas with limited resources and access to traditional care. The study provides a basis on which future research can be done to develop further and implement digital health strategies for the management and control of diabetes and hypertension.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.